Morningstar Investment Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Morningstar Investment Services's BIIB Position: Q3 2024 in Review
Morningstar Investment Services sold out of Biogen (BIIB) in Q3 2024, closing a stake of 1,245 shares — an estimated $285K sold.
Morningstar Investment Services first reported a position in BIIB in Q4 2015 and held it in 21 quarters. The position peaked at $7.88M in Q1 2019. 916 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.
- Morningstar Investment Services reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
- Morningstar Investment Services sold 1,245 Biogen shares in Q3 2024, an estimated $285K.
- Morningstar Investment Services first reported a position in Biogen in Q4 2015 and held it in 21 quarters.
- Morningstar Investment Services's Biogen position peaked at $7.88M in Q1 2019.
- 916 funds tracked by Wall St. Rank held Biogen as of Q3 2024.
Based on Morningstar Investment Services's 13F filing for Q3 2024, filed 7 Nov 2024.